The use of tranexamic acid to reduce blood loss during and after cesarean section

Bleeding after delivery is still the leading cause of maternal deaths especially in low resourced countries. Rates of delivery by cesarean section are increasing.One in three to four women are delivered by cesarean section.This trial is looking for new strategies to reduce blood loss after delivery by cesarean section.Tranexamic acid is a drug which prevents or delays lysis of blood clots after its formation .The formation of blood clot at the site of placental separation inside the uterus is an important mechanism to prevent bleeding after placental separation.This randomized controlled trial aims to evaluate the effectiveness and safety of tranexamic acid given to women at cesarean section.